Jane Huang, CMO, Hematology at BeiGene, Ltd. (BGNE), sold 4,700 shares at $212.53 ($986K) on 2020-07-29, disclosed to the SEC on 2020-07-31.
Open-market sale of $986k BGNE by CMO, Hematology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $208.35 | 1,301 | $271K | 27.5% |
| 2 | $208.35 | 1,301 | $271K | 27.5% |
| 3 | $208.91 | 700 | $146K | 14.8% |
| 4 | $211.31 | 200 | $42K | 4.3% |
| 5 | $212.53 | 400 | $85K | 8.6% |
| 6 | $213.56 | 399 |
| $85K |
| 8.6% |
| 7 | $213.56 | 399 | $85K | 8.6% |
| Total | $209.80 avg | 4,700 | $986K | 100% |
| Filing → |
| BGNE | SELL | 2021-12-02 | $755K | — | Filing → |
| BGNE | SELL | 2021-11-19 | $572K | — | Filing → |
| BGNE | SELL | 2021-10-21 | $559K | — | Filing → |